Patent for therapeutic memory-like NK cell production methods

The European Patent Office published patent application EP3538160A1 for methods and compositions enabling high-scale therapeutic production of memory-like natural killer (NK) cells. The patent was filed by University of Central Florida and Research Foundation, Inc., with inventors including Copik, Igarashi, Oyer, and Altomare. This A1 publication grants applicants exclusive rights to therapeutic applications of memory-like NK cell production methods for treating viral infections, cancer, and immune disorders.

Albumin-Based Nanomedicines Patent

EPO published patent EP3471740A1 for the University of Utah Research Foundation covering albumin-based nanomedicine compositions and methods for treating cancer. Inventors Kopeck and Yang developed formulations using human serum albumin as a drug carrier. The patent is classified under A61K47/64, A61K47/68, and A61P35/00 (antineoplastic agents).

Beta-Hydroxybutyrate Ester Therapeutic Compounds and Compositions

The European Patent Office published patent application EP3465335A1 for medium chain fatty acid esters of beta-hydroxybutyrate and butanediol, filed by The J. David Gladstone Institutes, The Regents of the University of California, and Ithaca College. The patent covers therapeutic compounds with applications across multiple disease indications including cancer (A61P 35/00), neurological conditions (A61P 25/28, 25/16, 25/08), kidney disease (A61P 13/12), and cardiovascular conditions (A61P 9/10).

Glycyrrhiza Glabra plant preparation antidote patent by Erber AG

Glycyrrhiza Glabra plant preparation antidote patent by Erber AG

TGFBETAR2 Endonuclease Variants and Gene Editing Compositions

The European Patent Office published patent EP3526334A1, granting Regeneron Pharmaceuticals exclusive rights to TGFBETAR2 endonuclease variants, compositions, and methods of use for gene editing applications. The patent designates 38 European member states, providing Regeneron broad territorial protection for its biotechnology innovations in the TGF-beta receptor II targeting space.

Engineered Fc Constructs Patent Application - Momenta Pharmaceuticals

The European Patent Office published patent application EP3464376A1 for Momenta Pharmaceuticals, Inc. on March 25, 2026. The application covers compositions and methods related to engineered Fc constructs with applications in immunology and therapeutic development. The publication designates 38 European member states.

Endoscope Patent - FUJIFILM

The European Patent Office published patent EP3459425A1 for an endoscope device filed by FUJIFILM Corporation. Inventors TANAKA, Koichi and YUKIIRI, Takeshi have been granted patent protection covering the designated European member states. The patent relates to endoscope technology classified under A61B 1/00 and G02B 23/24.

Hybrid Visible Near Infrared RGB Sensor Patent Granted

The European Patent Office granted patent EP3682202A1 to Kent Imaging Inc. for a hybrid visible and near-infrared imaging system using an RGB color filter array sensor. The patent covers technology for capturing both visible and near-infrared images with a single sensor, with applications in physiological assessment. The designated states cover most EU member states plus several European Economic Area countries.

Bed Having Physiological Event Detecting Feature

The European Patent Office published patent application EP3735156A1 by Sleep Number Corporation for a bed system capable of detecting physiological events. The invention utilizes sensors integrated into the bed to monitor health parameters. The patent names three inventors and covers designated states across the EU member states.

Polymer Membranes for Continuous Analyte Sensors

The European Patent Office published Dexcom, Inc.'s patent application EP3387993A2 titled 'Polymer Membranes for Continuous Analyte Sensors.' The patent covers electrochemical sensor technology using polymer membranes for continuous glucose monitoring. Inventors include Robert Boock, Monica A. Rixman, Huashi Zhang, Michael J. Estes, and Kristina Lawrence. The patent is designated across all EU member states.